Novel Vaccine against Chemo-resistant Ovarian Cancer
The Cancer Treatment Centers of America is launching a new cancer vaccine therapy that will be offered by the CTCA to chemo-resistant ovarian cancers and to be developed by AVAX Technologies, Inc.
Ovarian cancer is one of the hardest to detect in early stages, a complex cancer that is often resistant to chemotherapy.
The breakthrough treatment method uses the patient’s own tumor tissues to create a patient-specific vaccine and is combined with chemotherapy delivered directly into the abdominal cavity.
Read the full report.
Tags: cancer-vaccine, ovarian-cancerRelated Stories
POSTED IN: on anti-cancer ingredients, on ovarian cancer
0 opinions for Novel Vaccine against Chemo-resistant Ovarian Cancer
No one has left a comment yet. You know what this means, right? You could be first!
Have an opinion? Leave a comment: